These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31739105)

  • 1. Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway.
    Wei Y; Wu Y; Feng K; Zhao Y; Tao R; Xu H; Tang Y
    J Ethnopharmacol; 2020 Mar; 249():112404. PubMed ID: 31739105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AstragalosideⅣ against cardiac fibrosis by inhibiting TRPM7 channel.
    Lu J; Wang QY; Zhou Y; Lu XC; Liu YH; Wu Y; Guo Q; Ma YT; Tang YQ
    Phytomedicine; 2017 Jul; 30():10-17. PubMed ID: 28545665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-135a inhibits cardiac fibrosis induced by isoproterenol via TRPM7 channel.
    Wu Y; Liu Y; Pan Y; Lu C; Xu H; Wang X; Liu T; Feng K; Tang Y
    Biomed Pharmacother; 2018 Aug; 104():252-260. PubMed ID: 29775892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huoxin Pill inhibits isoproterenol-induced transdifferentiation and collagen synthesis in cardiac fibroblasts through the TGF-β/Smads pathway.
    Peng M; Yang M; Lu Y; Lin S; Gao H; Xie L; Huang B; Chen D; Shen A; Shen Z; Peng J; Chu J
    J Ethnopharmacol; 2021 Jul; 275():114061. PubMed ID: 33892065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
    J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
    Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
    J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia.
    Yang J; Li J; Lu J; Zhang Y; Zhu Z; Wan H
    J Ethnopharmacol; 2012 Mar; 140(1):64-72. PubMed ID: 22207211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells.
    Liu H; Wei W; Sun WY; Li X
    J Ethnopharmacol; 2009 Apr; 122(3):502-8. PubMed ID: 19429320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome.
    Wan Y; Xu L; Wang Y; Tuerdi N; Ye M; Qi R
    Eur J Pharmacol; 2018 Aug; 833():545-554. PubMed ID: 29913124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation.
    Li PF; He RH; Shi SB; Li R; Wang QT; Rao GT; Yang B
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of astragaloside IV on cognitive dysfunction in rats with cerebrally infarcted via TGF-β / Smad signaling pathway.
    Li L; Guo Y; Zhao Y; Wei J; Jin Y
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):87-92. PubMed ID: 32415932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.
    Dai H; Jia G; Lu M; Liang C; Wang Y; Wang H
    Mol Med Rep; 2017 Apr; 15(4):1765-1770. PubMed ID: 28260010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Combined Intervention of Electroacupuncture and Astragaloside IV on Myocardial Hypertrophy and TGF-β 1/Smad Signaling in Rats with Myocardial Fibrosis].
    Li JS; Zhu XY; Lu ML; Gao JH; Wang HX; Yu XC
    Zhen Ci Yan Jiu; 2017 Dec; 42(6):477-81. PubMed ID: 29318851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y; Yang S; Chen M; Zhang X; Zou Y; Zhang X
    J Ethnopharmacol; 2008 Jul; 118(2):264-70. PubMed ID: 18502066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of astragaloside-IV on bradycardia is involved in up-regulating klotho expression.
    Qiu X; Guo Q; Xiong W; Yang X; Tang YQ
    Life Sci; 2016 Jan; 144():94-102. PubMed ID: 26593401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of microRNA-202-3p protects against myocardial ischemia-reperfusion injury through activation of TGF-β1/Smads signaling pathway by targeting TRPM6.
    Wu HY; Wu JL; Ni ZL
    Cell Cycle; 2019 Mar; 18(5):621-637. PubMed ID: 30810438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential melastatin 7 (TRPM7) contributes to H2O2-induced cardiac fibrosis via mediating Ca(2+) influx and extracellular signal-regulated kinase 1/2 (ERK1/2) activation in cardiac fibroblasts.
    Guo JL; Yu Y; Jia YY; Ma YZ; Zhang BY; Liu PQ; Chen SR; Jiang JM
    J Pharmacol Sci; 2014; 125(2):184-92. PubMed ID: 24871786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.